Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy

Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis

(2013) Bradley C. Carthon et al.   BJU INTERNATIONAL

Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

(2013) S Nicholson et al.   BRITISH JOURNAL OF CANCER

Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis

(2012) Giuseppe Di Lorenzo et al.   BJU INTERNATIONAL

Proof of Activity of Anti–Epidermal Growth Factor Receptor–Targeted Therapy for Relapsed Squamous Cell Carcinoma of the Penis

(2011) Andrea Necchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study

(2010) Lance C. Pagliaro et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Significance of Extranodal Extension in Patients With Pathological Node Positive Penile Carcinoma

(2010) Niels M. Graafland et al.   JOURNAL OF UROLOGY

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)

(2008) C. Theodore et al.   ANNALS OF ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Taxanes in Combination with Cisplatin and Fluorouracil for Advanced Penile Cancer: Preliminary Results

(2008) Giorgio Pizzocaro et al.   EUROPEAN UROLOGY

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

(2008) C. Fakhry et al.   JNCI-Journal of the National Cancer Institute